Xilio Therapeutics, Inc. Common Stock (XLO)
Xilio Therapeutics, Inc. Common Stock (XLO) has a 19-report earnings history dating back to Dec 02, 2021. Its average absolute post-earnings move is ±9.86%, and 47.4% of those reactions were positive. Its largest post-earnings gain was +81.9% (Mar 28, 2024) and its largest decline was -21.88% (Aug 09, 2022). The next earnings report is predicted for 2026-08-11 (estimated).
Earnings reactions
How XLO moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±9.86%
Positive %
47.4%
Negative %
52.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 12, 2026 | ☀ PRE | -0.51% | open_in_new |
| Mar 23, 2026 | ☀ PRE | +2.56% | open_in_new |
| Nov 13, 2025 | ☀ PRE | -8.47% | open_in_new |
| Aug 14, 2025 | ☀ PRE | -2.21% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±9.86%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| EFFECT | 20260529 | open_in_new SEC.gov |
| S-3/A | 20260527 | open_in_new SEC.gov |
Frequently asked about XLO earnings
When does Xilio Therapeutics, Inc. Common Stock report earnings next? expand_more
Xilio Therapeutics, Inc. Common Stock (XLO)'s next earnings date is estimated for 2026-08-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does XLO stock move after earnings? expand_more
Over 19 reports, XLO has moved an average of ±9.86% the session after earnings, closing higher 47.4% of the time.
What was XLO's biggest post-earnings move? expand_more
XLO's largest post-earnings gain on record was +81.9% on Mar 28, 2024, and its largest decline was -21.88% on Aug 09, 2022.
Where can I find Xilio Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Xilio Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right